|
Foralumab TZLS-401 50 µg Clinical Trials
1 actively recruiting trial across 1 location
Boston, Massachusetts1 trial
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
Center for Alzheimer Research and Treatment, Brigham and Women's Hospital
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.